4.7 Review

MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma

Journal

Publisher

MDPI
DOI: 10.3390/ijms20092181

Keywords

miRNAs; cutaneous squamous cell carcinoma; skin cancer

Funding

  1. Instituto de Salud Carlos III cofinanciado con fondos FEDER [PI18/000587]
  2. Gerencia Regional de Salud de Castilla y Leon [GRS 1835/A/18]
  3. Programa de Intensificacion de la Actividad Investigadora de la Gerencia Regional de Salud de Castilla y Leon, Spain [INT/M/10/19]

Ask authors/readers for more resources

Cutaneous squamous cell carcinoma (CSCC) is the second most frequent cancer in humans and it can be locally invasive and metastatic to distant sites. MicroRNAs (miRNAs or miRs) are endogenous, small, non-coding RNAs of 19-25 nucleotides in length, that are involved in regulating gene expression at a post-transcriptional level. MicroRNAs have been implicated in diverse biological functions and diseases. In cancer, miRNAs can proceed either as oncogenic miRNAs (onco-miRs) or as tumor suppressor miRNAs (oncosuppressor-miRs), depending on the pathway in which they are involved. Dysregulation of miRNA expression has been shown in most of the tumors evaluated. MiRNA dysregulation is known to be involved in the development of cutaneous squamous cell carcinoma (CSCC). In this review, we focus on the recent evidence about the role of miRNAs in the development of CSCC and in the prognosis of this form of skin cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available